Related Experiment Video
Updated: Aug 30, 2026

Myocardial Infarction in Neonatal Mice, A Model of Cardiac Regeneration
Published on: May 24, 2016
Phosphoinositide 3-kinase regulates excitation-contraction coupling in neonatal cardiomyocytes
Susan A McDowell1, Eileen McCall, William F Matter
1Cardiovascular Research, Lilly Research Laboratories, Eli Lilly and Company, Indianapolis, IN 46285-0520, USA.
Abstract:
The phosphoinositide 3-kinase (PI3K) inhibitor LY-294002 decreased steady-state contraction in neonatal rat ventricular myocytes (NRVM). To determine whether the effect on steady-state contraction could be due to decreased intracellular Ca(2+) content, Ca(2+) content was assessed with fluorescent plate reader analysis by using the caffeine-releasable Ca(2+) stores as an index of sarcoplasmic reticulum (SR) Ca(2+) content. Caffeine-releasable Ca(2+) content was diminished in a dose-dependent manner with LY-294002, suggesting that the decrease in steady-state contraction was due to diminished intracellular Ca(2+) content. Activation of the L-type Ca(2+) channel by BAY K 8644 was attenuated by LY-294002, suggesting the effect of LY-294002 is to reduce Ca(2+) influx at this channel. To investigate whether additional proteins involved in excitation-contraction (EC) coupling are likewise regulated by PI3K activity, the effects of compounds acting at sarco(endo)plasmic reticulum Ca(2+)-ATPase (SERCA2a), the ryanodine receptor, and the Na/Ca exchanger (NCX) were compared with LY-294002. Inhibition of SERCA2a by thapsigargin increased basal Ca(2+) levels in contrast to LY-294002, indicating that SERCA2a activity is sustained in the presence of LY-294002. Ryanodine decreased SR Ca(2+) content. The additive effect with coadministration of LY-294002 could be attributed to a decrease in Ca(2+) influx at the L-type Ca(2+) channel. The NCX inhibitor Ni(2+) was used to investigate whether the decrease in intracellular Ca(2+) content with LY-294002 could be due to inhibition of the NCX reverse-mode activity. The minimal effect of LY-294002 with Ni(2+) suggests that the primary effect of LY-294002 on EC coupling occurs through inhibition of PI3K-mediated L-type Ca(2+) channel activity.
Insights
The phosphoinositide 3-kinase (PI3K) inhibitor LY-294002 reduced heart muscle contraction by decreasing intracellular calcium. This effect is primarily due to reduced calcium influx through L-type calcium channels, not other proteins involved in excitation-contraction coupling.
Area of Science:
- Cardiology
- Molecular Biology
- Cell Physiology
Background:
- Phosphoinositide 3-kinase (PI3K) signaling plays a crucial role in cardiac function.
- Understanding the precise mechanisms by which PI3K regulates excitation-contraction (EC) coupling is essential for cardiac research.
Purpose of the Study:
- To investigate the impact of PI3K inhibition on intracellular calcium handling and steady-state contraction in neonatal rat ventricular myocytes (NRVM).
- To elucidate the specific molecular targets of PI3K in the regulation of EC coupling.
Main Methods:
- Utilized the PI3K inhibitor LY-294002 to assess effects on NRVM contraction and intracellular Ca(2+) content.
- Measured caffeine-releasable Ca(2+) stores as an index of sarcoplasmic reticulum (SR) Ca(2+) content.
- Investigated the influence of LY-294002 on L-type Ca(2+) channels, SERCA2a, ryanodine receptors, and the Na/Ca exchanger (NCX).
Main Results:
- LY-294002 dose-dependently decreased steady-state contraction and diminished SR Ca(2+) content in NRVM.
- LY-294002 attenuated L-type Ca(2+) channel activation by BAY K 8644, indicating reduced Ca(2+) influx.
- PI3K activity does not appear to sustain SERCA2a function, and its primary effect on EC coupling involves L-type Ca(2+) channels.
Conclusions:
- The PI3K inhibitor LY-294002 impairs cardiac contraction by reducing intracellular Ca(2+) content, primarily through inhibition of PI3K-mediated L-type Ca(2+) channel activity.
- These findings highlight a critical role for PI3K in regulating Ca(2+) influx and EC coupling in cardiomyocytes.
Related Concept Videos
Phosphoinositides and PIPs
Different phosphoinositides are synthesized and recruited on the cytosolic face of the plasma membrane. The localization of specific phosphoinositides concentrated in separate membrane...
Cardiac Action Potential
The cardiac action potential process involves a series of phases characterized by the movement of ions across the cardiac cell membranes, leading to the depolarization and repolarization of the cardiac myocytes.
Ionic Basis of Cardiac Action Potentials
Electrophysiology of Normal Cardiac Rhythm
IP3/DAG Signaling Pathway
G-Protein Gated Ion Channels
Sensory organs,...
Excitation-Contraction Coupling in Skeletal Muscles
When an action potential...

